HIST1H4A (Ab-5) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
We typically dispatch products within 1-3 business days after receiving your order. Delivery times may vary based on the purchasing method or location. For specific delivery timelines, please consult your local distributor.
Synonyms
dJ160A22.1 antibody; dJ160A22.2 antibody; dJ221C16.1 antibody; dJ221C16.9 antibody; FO108 antibody; H4 antibody; H4.k antibody; H4/a antibody; H4/b antibody; H4/c antibody; H4/d antibody; H4/e antibody; H4/g antibody; H4/h antibody; H4/I antibody; H4/j antibody; H4/k antibody; H4/m antibody; H4/n antibody; H4/p antibody; H4_HUMAN antibody; H4F2 antibody; H4F2iii antibody; H4F2iv antibody; H4FA antibody; H4FB antibody; H4FC antibody; H4FD antibody; H4FE antibody; H4FG antibody; H4FH antibody; H4FI antibody; H4FJ antibody; H4FK antibody; H4FM antibody; H4FN antibody; H4M antibody; HIST1H4A antibody; HIST1H4B antibody; HIST1H4C antibody; HIST1H4D antibody; HIST1H4E antibody; HIST1H4F antibody; HIST1H4H antibody; HIST1H4I antibody; HIST1H4J antibody; HIST1H4K antibody; HIST1H4L antibody; HIST2H4 antibody; HIST2H4A antibody; Hist4h4 antibody; Histone 1 H4a antibody; Histone 1 H4b antibody; Histone 1 H4c antibody; Histone 1 H4d antibody; Histone 1 H4e antibody; Histone 1 H4f antibody; Histone 1 H4h antibody; Histone 1 H4i antibody; Histone 1 H4j antibody; Histone 1 H4k antibody; Histone 1 H4l antibody; Histone 2 H4a antibody; histone 4 H4 antibody; Histone H4 antibody; MGC24116 antibody
Target Names
HIST1H4A
Uniprot No.

Target Background

Function
Histone H4 serves as a core component of the nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to cellular machinery that relies on DNA as a template. This crucial role of histones extends to the regulation of transcription, DNA repair, DNA replication, and chromosomal stability. The accessibility of DNA is tightly controlled by a complex interplay of post-translational modifications of histones, collectively known as the histone code. These modifications, along with nucleosome remodeling, contribute to the intricate regulation of gene expression and other cellular processes.
Gene References Into Functions
  1. Research demonstrates that PP32 and SET/TAF-Ibeta proteins inhibit HAT1-mediated H4 acetylation. PMID: 28977641
  2. Studies suggest that post-translational modifications of histones, specifically trimethylation of lysine 36 in H3 (H3K36me3) and acetylation of lysine 16 in H4 (H4K16ac), play a role in DNA damage repair. H3K36me3 is found to stimulate H4K16ac upon DNA double-strand breaks, and this epigenetic modification requires the involvement of SETD2, LEDGF, and KAT5 (SETD2 = SET domain containing 2; LEDGF = lens epithelium-derived growth factor; KAT5 = lysine acetyltransferase 5). PMID: 28546430
  3. Data reveal that Omomyc protein co-localizes with proto-oncogene protein c-myc (c-Myc), protein arginine methyltransferase 5 (PRMT5), and histone H4 H4R3me2s-enriched chromatin domains. PMID: 26563484
  4. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription. PMID: 25788266
  5. Systemic lupus erythematosus appears to be linked to an imbalance between histone acetyltransferases and histone deacetylase enzymes, favoring pathological H4 acetylation. PMID: 25611806
  6. Sumoylated human histone H4 prevents chromatin compaction by inhibiting long-range internucleosomal interactions. PMID: 25294883
  7. Acetylation at lysine 5 of histone H4 is associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus. PMID: 25283865
  8. An increase in histone H4 acetylation caused by hypoxia in human neuroblastoma cell lines correlates with increased levels of N-myc transcription factor in these cells. PMID: 24481548
  9. Data indicate that histone assembly in the G1 phase is restricted to CENP-A and H4. PMID: 23363600
  10. This study focused on the distribution of a specific histone modification, namely H4K12ac, in human sperm and characterized its specific enrichment sites in promoters throughout the whole human genome. PMID: 22894908
  11. SRP68/72 heterodimers are identified as major nuclear proteins whose binding of histone H4 tail is inhibited by H4R3 methylation. PMID: 23048028
  12. TNF-alpha inhibition of AQP5 expression in human salivary gland acinar cells is attributed to the epigenetic mechanism of suppressing acetylation of histone H4. PMID: 21973049
  13. Findings suggest that global histone H3 and H4 modification patterns are potential markers for tumor recurrence and disease-free survival in non-small cell lung cancer. PMID: 22360506
  14. HAT1 differentially impacts nucleosome assembly of H3.1-H4 and H3.3-H4. PMID: 22228774
  15. Phosphorylation of histone H4 Ser 47, catalyzed by the PAK2 kinase, promotes nucleosome assembly of H3.3-H4 and inhibits nucleosome assembly of H3.1-H4 by increasing the binding affinity of HIRA to H3.3-H4 and reducing the association of CAF-1 with H3.1-H4. PMID: 21724829
  16. The imatinib-induced hemoglobinization and erythroid differentiation in K562 cells are associated with global histone H4. PMID: 20949922
  17. Research findings reveal the molecular mechanisms whereby the DNA sequences within specific gene bodies are sufficient to nucleate the monomethylation of histone H4 lysine 200, which, in turn, reduces gene expression by half. PMID: 20512922
  18. Expression of Histone H4 is downregulated by zinc and upregulated by docosahexaenoate in a neuroblastoma cell line. PMID: 19747413
  19. Low levels of histone acetylation are associated with the development and progression of gastric carcinomas, possibly through alterations in gene expression. PMID: 12385581
  20. Overexpression of MTA1 protein and the acetylation level of histone H4 protein are closely related. PMID: 15095300
  21. Peptidylarginine deiminase 4 (PAD4) regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine. Data suggest that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histones. PMID: 15345777
  22. The lack of biotinylation of K12 in histone H4 is an early signaling event in response to double-strand breaks. PMID: 16177192
  23. Incorporation of acetylated histone H4-K16 into nucleosomal arrays inhibits the formation of compact 30-nanometer-like fibers and impedes the ability of chromatin to form cross-fiber interactions. PMID: 16469925
  24. Apoptosis is associated with global DNA hypomethylation and histone deacetylation events in leukemia cells. PMID: 16531610
  25. BTG2 contributes to retinoic acid activity by favoring differentiation through a gene-specific modification of histone H4 arginine methylation and acetylation levels. PMID: 16782888
  26. A relationship exists between histone H4 modification, epigenetic regulation of BDNF gene expression, and long-term memory for extinction of conditioned fear. PMID: 17522015
  27. The H4 tail and its acetylation play novel roles in mediating the recruitment of multiple regulatory factors that can alter chromatin states for transcription regulation. PMID: 17548343
  28. Brd2 bromodomain 2 is monomeric in solution and dynamically interacts with H4-AcK12. Additional secondary elements in the long ZA loop may be a common characteristic of BET bromodomains. PMID: 17848202
  29. Spermatids Hypac-H4 impairment in mixed atrophy did not deteriorate further by AZFc region deletion. PMID: 18001726
  30. The SET8 and PCNA interaction couples H4-K20 methylation with DNA replication. PMID: 18319261
  31. H4K20 monomethylation and PR-SET7 are crucial for L3MBTL1 function. PMID: 18408754
  32. High expression of acetylated H4 is more prevalent in aggressive cutaneous T-cell lymphoma compared to indolent forms. PMID: 18671804
  33. Findings indicate a significant role of histone H4 modifications in bronchial carcinogenesis. PMID: 18974389
  34. Results indicate that acetylation of histone H4 K16 during S-phase enables early replicating chromatin domains to acquire the H4K16ac-K20me2 epigenetic label that persists on the chromatin throughout mitosis and is deacetylated in early G1-phase of the next cell cycle. PMID: 19348949
  35. Acetylated H4 is overexpressed in diffuse large B-cell lymphoma and peripheral T-cell lymphoma relative to normal lymphoid tissue. PMID: 19438744
  36. The release of histone H4 by holocrine secretion from the sebaceous gland may play a significant role in innate immunity. PMID: 19536143
  37. Histone modifications, including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4, may be involved in CD11b transcription during HL-60 leukemia cell reprogramming to terminal differentiation. PMID: 19578722
  38. A role of Cdk7 in regulating elongation is further suggested by enhanced histone H4 acetylation and diminished histone H4 trimethylation on lysine 36, two marks of elongation, within genes when the kinase was inhibited. PMID: 19667075
  39. Data showed the dynamic fluctuation of histone H4 acetylation levels during mitosis, as well as acetylation changes in response to structurally distinct histone deacetylase inhibitors. PMID: 19805290
  40. Data directly implicate BBAP in the monoubiquitylation and additional posttranslational modification of histone H4 and an associated DNA damage response. PMID: 19818714

Show More

Hide All

Database Links

HGNC: 4781

OMIM: 142750

KEGG: hsa:121504

STRING: 9606.ENSP00000367034

UniGene: Hs.143080

Involvement In Disease
Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6.
Protein Families
Histone H4 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is HIST1H4A (Ab-5) Antibody and what epitope does it recognize?

HIST1H4A (Ab-5) Polyclonal Antibody is a rabbit-derived antibody that specifically recognizes the peptide sequence around the site of Lysine 5 derived from Human Histone H4 . This antibody targets histone H4 protein (accession number P62805) which is one of the core histone proteins comprising the nucleosome . The "(Ab-5)" designation specifically indicates that this antibody targets the region containing the lysine 5 residue of histone H4, a site that can undergo acetylation as a post-translational modification critical for regulating chromatin structure and gene expression .

What applications is HIST1H4A (Ab-5) Antibody validated for?

The HIST1H4A (Ab-5) Polyclonal Antibody has been validated for multiple experimental applications commonly used in epigenetic and chromatin research:

ApplicationValidatedRecommended DilutionNotes
ELISAYesProtocol-dependentFor quantitative detection
Western Blot (WB)Yes0.1 μg/mL typicalDetects band at ~12 kDa
Immunohistochemistry (IHC)YesTissue-dependentFor fixed tissue sections
Immunofluorescence (IF)Yes0.1 μg/mLNuclear localization pattern
Immunoprecipitation (IP)YesProtocol-dependentFor protein complex isolation

The antibody shows specific nuclear staining in immunofluorescence applications, consistent with the known nuclear localization of histone proteins .

How does HIST1H4A (Ab-5) Antibody compare to antibodies detecting acetylated histone H4?

While HIST1H4A (Ab-5) Antibody recognizes the region around lysine 5 regardless of modification status, antibodies specifically against acetylated H4K5 (such as those described in search result ) detect only the acetylated form of this residue. The acetylation of H4K5 is particularly significant as:

  • H4K5 acetylation is catalyzed by the Hat1-RbAp46 complex

  • This modification is prominent on newly synthesized histones during DNA replication

  • It plays a critical role in nucleosome assembly pathways

  • The modification can be experimentally induced using histone deacetylase inhibitors like sodium butyrate

When designing experiments to study histone modifications, researchers should select antibodies based on whether they wish to detect total H4 protein or specifically its acetylated form at K5.

What controls should be included when using HIST1H4A (Ab-5) Antibody in experiments?

Proper experimental controls are essential when working with histone antibodies:

Control TypePurposeImplementation
Positive ControlConfirms antibody activityHeLa cells express histone H4
Negative ControlAssesses non-specific bindingPrimary antibody omission
Treatment ControlValidates biological responseSodium butyrate increases H4K5 acetylation
Loading ControlNormalizes protein amountNon-variable histone or nuclear protein
Peptide CompetitionConfirms specificityPre-incubation with immunizing peptide

For validation of acetylation-specific antibodies, treatment of cells with histone deacetylase inhibitors like sodium butyrate can increase the signal, as demonstrated in the R&D Systems documentation for H4K5ac antibodies .

How should I optimize immunofluorescence protocols for HIST1H4A (Ab-5) Antibody?

Successful immunofluorescence with histone antibodies requires careful optimization:

  • Fixation:

    • 4% paraformaldehyde (10-15 minutes) typically preserves nuclear architecture

    • Methanol fixation may improve access to some nuclear epitopes

    • Test multiple fixation methods with your specific cell type

  • Permeabilization:

    • Include adequate permeabilization (0.1-0.5% Triton X-100) to ensure nuclear access

    • Overly harsh permeabilization may extract nuclear proteins

  • Antibody concentration:

    • Start with recommended dilution (0.1 μg/mL has been successful for similar antibodies)

    • Titrate to determine optimal signal-to-noise ratio

  • Signal detection:

    • Nuclear counterstain (DAPI) helps confirm proper nuclear localization

    • Fluorophore selection should avoid spectral overlap with other channels

    • Confocal microscopy may provide better resolution of nuclear structures

  • Pattern interpretation:

    • Expect nuclear localization with possible enrichment in euchromatic or heterochromatic regions

    • Different cell types may show variation in staining patterns

How can ChIP protocols be optimized for HIST1H4A (Ab-5) Antibody?

Chromatin immunoprecipitation (ChIP) with histone antibodies requires specific considerations:

  • Crosslinking conditions:

    • Standard 1% formaldehyde for 10 minutes is typically sufficient

    • Over-crosslinking can mask epitopes and reduce efficiency

  • Sonication parameters:

    • Aim for fragments between 200-500 bp

    • Verify fragmentation by agarose gel before proceeding

  • Antibody amount:

    • Typically 2-5 μg per ChIP reaction

    • Perform antibody titration to determine optimal amount

  • Washing stringency:

    • Balance between reducing background and maintaining specific interactions

    • Include high-salt washes to reduce non-specific binding

  • Controls for ChIP experiments:

    • Input sample (pre-immunoprecipitation)

    • IgG control from same species as primary antibody

    • Positive control loci (housekeeping genes for active marks)

    • Negative control loci (silenced genes or heterochromatic regions)

  • Validation approaches:

    • qPCR of known target regions before proceeding to sequencing

    • Compare enrichment profiles with published datasets for H4K5ac

How can HIST1H4A (Ab-5) Antibody be used to study nucleosome assembly during DNA replication?

Histone H4 acetylation at lysine 5 plays a critical role in replication-coupled nucleosome assembly:

  • Experimental design approaches:

    • Synchronize cells and collect at different points in S phase

    • Combine with EdU labeling to identify actively replicating regions

    • ChIP-seq to map genome-wide distribution during replication

  • Mechanistic insights:

    • Newly synthesized H4 is acetylated at K5 and K12 by the HAT1 holoenzyme (Hat1-RbAp46)

    • This pattern facilitates interaction with histone chaperones during nucleosome assembly

    • Hat1-RbAp46 acetylates H4 in H3.1-H4 complexes more efficiently than in H3.3-H4 complexes

  • Analysis considerations:

    • Compare patterns in early vs. late replicating chromatin domains

    • Assess correlation with other replication-associated histone marks

    • Evaluate changes in different cell types or developmental stages

This research direction can provide insights into how chromatin states are propagated through cell division, as Hat1-RbAp46-mediated acetylation impacts nucleosome assembly differently for replication-dependent H3.1 versus replication-independent H3.3 histone variants .

How does H4K5 acetylation interact with other histone modifications in the histone code?

H4K5 acetylation functions within a complex network of histone modifications:

Understanding these interactions can provide insights into the complex regulatory mechanisms that govern chromatin structure and function.

What role does H4K5 acetylation play in the differential assembly of histone variants?

Recent research has revealed interesting connections between H4K5 acetylation and histone variant deposition:

  • Variant-specific interactions:

    • Hat1-RbAp46 acetylates H4 in H3.1-H4 complexes more efficiently than in H3.3-H4 complexes

    • More Hat1 and RbAp46 co-purify with H3.1 than with H3.3

    • H4K5,12ac enrichment on H4 that co-purifies with H3.1 compared to H3.3

  • Assembly pathway differences:

    • H3.1-containing nucleosomes are primarily assembled during DNA replication

    • H3.3-containing nucleosomes are assembled in a replication-independent manner

    • Different chaperone systems: CAF-1 for H3.1 versus HIRA for H3.3

  • Experimental approaches:

    • Co-immunoprecipitation to study interactions between modified H4 and chaperones

    • Pulse-chase experiments to track newly synthesized histones

    • FRAP (Fluorescence Recovery After Photobleaching) to measure dynamics

  • Functional implications:

    • Different acetylation patterns may help direct histones to appropriate assembly pathways

    • May contribute to maintaining distinct functions of histone variants

    • Could influence epigenetic inheritance through cell division

This differential acetylation pattern suggests a mechanistic link between histone modification and the choice of assembly pathway, potentially contributing to the establishment and maintenance of chromatin domains .

Why might Western blots with HIST1H4A (Ab-5) Antibody show unexpected bands?

Multiple or unexpected bands in Western blots can occur for several reasons:

  • Common causes of multiple bands:

Band PatternPossible CauseSolution Strategy
Higher MW bands (~24 kDa)Histone dimersIncrease sample denaturation
Higher MW bands (varied)Ubiquitinated/SUMOylated formsVerify with modification-specific antibodies
Lower MW bandsProteolytic degradationAdd protease inhibitors, keep samples cold
Multiple bands at ~12-15 kDaDifferent post-translational modificationsCompare with modification-specific antibodies
  • Validation approaches:

    • The primary H4 band should appear at approximately 12 kDa

    • Use recombinant H4 protein as a size control

    • Perform peptide competition assays to identify specific bands

    • Compare with other validated H4 antibodies

  • Technical optimization:

    • Use high percentage gels (15-18%) for better resolution of histone proteins

    • Optimize transfer conditions for small proteins

    • Consider specialized histone extraction protocols

When optimizing Western blot conditions, the R&D Systems documentation notes successful detection using PVDF membrane under reducing conditions with their specific buffer system .

How should variations in nuclear staining patterns be interpreted?

Nuclear staining patterns can provide insights into chromatin organization and histone distribution:

  • Common patterns and their interpretation:

    • Even nuclear distribution: typical for many histone modifications

    • Peripheral enrichment: seen with certain histone variants (H1.2, H1.3, H1.5)

    • Punctate pattern: may indicate enrichment in heterochromatic regions

    • Exclusion from nucleoli: common for many histone marks

  • Cell-type specific considerations:

    • Different cell types may show variant-specific distribution patterns

    • Cell lines lacking certain histone variants may show compensatory distribution of others

    • Compare with known nuclear architecture markers

  • Technical factors affecting pattern interpretation:

    • Fixation method can alter nuclear architecture

    • Antibody concentration affects signal-to-noise ratio

    • Imaging parameters (exposure, contrast) influence pattern visibility

    • Deconvolution may improve resolution of nuclear structures

  • Validation approaches:

    • Co-staining with markers of nuclear domains (heterochromatin, nucleoli)

    • Comparison with other histone modification antibodies

    • Correlation with DAPI intensity (indicates DNA density)

Research has shown that certain histone variants maintain consistent nuclear distribution patterns across different cell types, suggesting fundamental roles in nuclear organization .

How can ChIP-seq data quality with HIST1H4A (Ab-5) Antibody be assessed?

Quality assessment of ChIP-seq data is critical for valid biological interpretation:

  • Key quality metrics:

    • Signal-to-noise ratio (enrichment over background)

    • Peak shape characteristics (sharp vs. broad)

    • Correlation with known genomic features

    • Reproducibility between replicates

  • Computational analysis considerations:

    • Appropriate peak calling algorithms for histone modifications (typically broad)

    • Normalization methods accounting for sequencing depth

    • Comparison to input or IgG control samples

    • Visualization of coverage at known positive and negative regions

  • Biological validation approaches:

    • Correlation with gene expression data

    • Comparison with published datasets for similar modifications

    • Verification of enrichment at expected genomic features

    • qPCR validation of selected loci

  • Common pitfalls and solutions:

    • Low enrichment: optimize antibody amount, chromatin amount, wash conditions

    • High background: increase wash stringency, optimize antibody concentration

    • Poor reproducibility: standardize protocol, increase replicate number

    • Unexpected distribution: verify antibody specificity, consider cell type differences

Proper quality assessment ensures that downstream biological interpretations are based on reliable data, particularly important when studying histone modifications that may have subtle genomic distributions.

How are new technologies enhancing our understanding of H4K5 acetylation dynamics?

Recent technological advances are providing unprecedented insights into histone modifications:

  • Single-cell approaches:

    • Single-cell ChIP-seq and CUT&Tag for cellular heterogeneity analysis

    • Single-molecule imaging to track modification dynamics in living cells

    • Integration with single-cell transcriptomics

  • Genome editing applications:

    • CRISPR-based histone modification mapping

    • Creation of acetylation-mimetic or deficient histone mutants

    • Site-specific introduction of modified histones

  • Structural biology insights:

    • Cryo-EM structures of nucleosomes with modified histones

    • Understanding how modifications alter nucleosome structure

    • Visualization of histone-chaperone interactions

  • Quantitative proteomics:

    • PTM-specific quantification using mass spectrometry

    • Multiplexed analysis of modification combinations

    • Temporal dynamics during cell cycle progression

These technologies are driving new understanding of how H4K5 acetylation contributes to chromatin regulation and nucleosome assembly pathways.

What are emerging concepts regarding H4K5 acetylation in disease contexts?

Understanding histone modifications in disease contexts is an active area of research:

  • Cancer biology implications:

    • Altered histone modification patterns in various malignancies

    • Potential diagnostic or prognostic biomarkers

    • Therapeutic targeting of enzymes regulating H4K5 acetylation

  • Neurodegenerative disease connections:

    • Disrupted histone acetylation in neurodegenerative disorders

    • HDAC inhibitors as potential therapeutic agents

    • Role in neuronal gene expression regulation

  • Developmental disorders:

    • Importance in embryonic development and cellular differentiation

    • Mutations in histone modifying enzymes in congenital disorders

    • Transgenerational epigenetic inheritance considerations

  • Research methodologies:

    • Patient-derived samples for modification profiling

    • Disease models to study dynamic changes

    • Integration with genetic and genomic data

This research area holds promise for identifying new biomarkers and therapeutic targets based on histone modification patterns.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.